Medicine & Life Sciences
Transplants
100%
Stem Cell Transplantation
99%
Survival
80%
Hematopoietic Stem Cell Transplantation
73%
Multiple Myeloma
62%
Graft vs Host Disease
59%
Allogeneic Cells
56%
Immunoglobulin Light-chain Amyloidosis
54%
Cell Transplantation
53%
Primary Myelofibrosis
40%
Hematopoietic Stem Cells
38%
Melphalan
38%
Stem Cells
37%
Amyloidosis
33%
Acute Myeloid Leukemia
31%
Mortality
28%
Peripheral Blood Stem Cell Transplantation
27%
Myelodysplastic Syndromes
26%
Therapeutics
24%
Transplantation
21%
Bone Marrow
20%
Light
20%
Progression-Free Survival
19%
Tissue Donors
19%
N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide
18%
fludarabine
18%
Recurrence
17%
Hematologic Neoplasms
17%
Plasma Cells
14%
Lenalidomide
14%
Cytogenetics
13%
Biomarkers
13%
Unrelated Donors
13%
Transplant Recipients
12%
Drug Therapy
12%
venetoclax
12%
POEMS Syndrome
11%
Leukemia
11%
Precursor Cell Lymphoblastic Leukemia-Lymphoma
11%
Confidence Intervals
11%
Peripheral Blood Stem Cells
11%
GATA2 Deficiency
11%
Homologous Transplantation
11%
Lymphocytes
11%
Incidence
11%
Whole-Body Irradiation
11%
Safety
10%
Anemia
10%
Karyotype
10%
Chimerism
9%